New diabetes clinical trial: Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes
Published on: October 24, 2022 at 11:00AM
Conditions: Type2diabetes; Insulin Resistance
Interventions: Drug: Metformin; Drug: Dapagliflozin; Drug: Fixed-dose combination of metformin and pioglitazone (500mg metformin plus 15mg pioglitazone)
Sponsor: Nanjing First Hospital, Nanjing Medical University
Not yet recruiting
https://ift.tt/21Gl5YJ
Conditions: Type2diabetes; Insulin Resistance
Interventions: Drug: Metformin; Drug: Dapagliflozin; Drug: Fixed-dose combination of metformin and pioglitazone (500mg metformin plus 15mg pioglitazone)
Sponsor: Nanjing First Hospital, Nanjing Medical University
Not yet recruiting
https://ift.tt/21Gl5YJ
Comments
Post a Comment